Physician profile
Charles Ma
NPI 1205377579
$849.72
in general payments reported to CMS, 2019-2025
7 companies · $20.81 in 2025
The $20.81 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $437 · 2023: $327 · 2024: $64.94 · 2025: $20.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $304.70 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $243.00 | 2023 | Tezspire, Fasenra |
| Alk-Abello, INC | $114.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.11 | 2023 | Takhzyro |
| Depuy Synthes Sales INC. | $43.93 | 2024-2025 | Matrixrib |
| Abiomed | $41.82 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $17.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.